Navigation Links
Howard Dean to Speak at the 2010 DTC National Conference
Date:2/10/2010

Dean scheduled to deliver keynote speech on April 7, 2010 at the J.W. Marriott Hotel in Washington D.C.

Florham Park, N.J. (PRWEB) February 10, 2010 -- DTC Perspectives, Inc., the leading conference, training and publishing company for direct-to-consumer (DTC) marketing, is proud to announce that former Vermont Governor and licensed medical doctor Howard Dean will act as a keynote speaker at the 2010 DTC National Conference to be held April 7-9 at the J.W. Marriott Hotel in Washington D.C. Dean will address the conference delegates on day one of the event (Apr. 7) by posing the question, “What is Real Healthcare Reform?” Interested parties can register for the conference at www.DTCPerspectives.com.

Former Vermont Governor Howard Dean founded Democracy for America (DFA) in 2004 to build on the grassroots momentum for reform that his bid for the presidency sparked in 2004. The movement propelled DFA into a successful national organization committed to the "50 State Strategy" with more than 1 million members. In 2005, Governor Dean was elected to chair the Democratic National Committee (DNC) and from 2005–2009 he spearheaded the DNC's support of the Democratic Party, setting up Democrats to take back Congress in 2006 and win the White House in 2008. Upon leaving the DNC early last year, Governor Dean has returned to DFA as a senior adviser on the issue of healthcare and he has become a leading commentator on the various reform proposals that moved through Congress in 2009.

Additional keynote speakers scheduled to appear at the 2010 conference include global industry leaders Steve Case, founder of AOL, and Amy Cowan, Head of Industry, Google; Pharmaceutical marketers Tom Curatolo, Product Director, Vyvanse Marketing, Shire U.S., Inc., Tim Gamble, Global Market Analytics, Pfizer Inc., Sam Trujillo, Director of Consumer Marketing, Bayer HealthCare Pharmaceuticals, Paul Stevenson, Senior Product Manager, Novo Nordisk, and Richard Baron, Executive Director of Customer Development Marketing, Boehringer Ingelheim.

The DTC National Conference is designed to provide DTC marketers with an opportunity to learn from industry thought leaders and discuss the latest innovations in DTC marketing. Over the three day conference, the more than 550 attendees benefit from case studies, new market research, media & marketing gurus and networking opportunities. Attendance is recommended for all industry members, including pharmaceutical brand team members, agency executives, media buyers and planners, market researchers, media partners and solution providers.

For more information on the 2010 DTC National Conference Agenda or for conference registration, please visit our Website, www.DTCperspectives.com or call Debra Sander at (973) 377-2106 ex 221.

DTC Perspectives, Inc. is a conference, training and publishing company that specializes in the analysis of pharmaceutical product consumer marketing. It is our goal to serve as the premier information exchange forum for DTC marketers with the publication of DTC Perspectives magazine as well as through attendance at our highly respected DTC Conference Series.


###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3581444.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
2. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
3. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Micrus Endovascular Corporation
4. UT Southwestern researcher named Howard Hughes Medical Institute investigator
5. CVS Caremarks Howard McLure Elected New PCMA Board Chairman
6. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against WellCare Health Plans, Inc.
7. Law Offices of Howard G. Smith Announces 14 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Care Investment Trust Inc.
8. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Micrus Endovascular Corporation
9. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Howard Dean to Speak at the 2010 DTC National Conference 
(Date:4/28/2017)... ... 28, 2017 , ... Ushio America proudly introduces the new ... energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts ... rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to ... Care Medicine will host industry leaders for the annual spring Convention & Expo, ... the industry adapt to the issues currently affecting urgent care and on-demand healthcare. ...
(Date:4/28/2017)... ... 28, 2017 , ... Researchers at Moffitt Cancer Center ... CentrePoint Data Hub in a sample of participants enrolled in an ongoing cancer ... monitoring solutions for the global scientific community. The company’s new CentrePoint Data Hub ...
(Date:4/28/2017)... ... , ... Rob Lowe is a popular actor that has been in many ... educational purpose as the host of the “Informed” series. The program focuses on many ... the series focuses on thyroid cancer. , Although thyroid cancer is an uncommon type ...
(Date:4/27/2017)... Jacksonville, Florida (PRWEB) , ... April 27, 2017 , ... ... qualified candidates. But they will rapidly reject an outdated healthcare executive resume. , “If ... good look at your executive resume and wondering if it’s as ready as you ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology: